Tag Archives: SHP465

Shire plc: U.S. FDA acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for SHP465

Posted on 20, January 2017 by

Lexington, Mass., USA, 20-Jan-2017 — /EuropaWire/ — Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the Class 2 resubmission of a New Drug Application (NDA) for SHP465, a long-acting, triple-bead, … Read the full press release →

Posted in Healthcare, Ireland, Pharma & Biotech

Tagged , , , , , , , ,